Retraction notices

Pharmacogenomic Analysis of Response to Topical Tumor Necrosis Factor α Antagonist Licaminlimab (OCS-02) in Dry Eye Disease

Type
Retraction
Notice date
10/1/2024 0:00
Journal
Cornea
Publisher
Wolters Kluwer - Lippincott Williams & Wilkins
Notice DOI
10.1097/ico.0000000000003640
Original paper DOI
10.1097/ico.0000000000003510

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.